Tirzepatide demonstrates superior weight loss results in clinical trials, with patients losing 15-22% of body weight compared to 10-15% with semaglutide, though both medications are highly effective GLP-1 options
Synaptogenesis is the cellular basis of this compensation, and no known compound drives synaptogenesis as powerfully as Dihexa
Initial sensitivity and tolerance to ethanol in mice: correlations among open field activity, hypothermia, and loss of righting reflex
For weight loss, the injections are approved for people with a BMI of 27 and above, and weight loss surgery is approved for a BMI of 30 and above, though its more common among people with with a BMI over 35
Its action mitigates potential damage from byproducts like hydroxyl radicals and peroxynitrite, which can accrue under oxidative stress [34]
This article is for educational purposes only and is not a substitute for professional medical advice